Cited by 111Bioinformatics and Genomic NetworksComputational Drug Discovery MethodsMachine Learning in Healthcare

Discovery of drug-omics associations in type 2 diabetes with generative deep-learning models

Open access
Allesøe, Rosa Lundbye, Lundgaard, Agnete Troen, Hernández Medina, Ricardo, Aguayo-Orozco, Alejandro, Johansen, Joachim, Nissen, Jakob Nybo, Brorsson, Caroline, Mazzoni, Gianluca +162 more·2023·Nature Biotechnology

Abstract

The application of multiple omics technologies in biomedical cohorts has the potential to reveal patient-level disease characteristics and individualized response to treatment. However, the scale and heterogeneous nature of multi-modal data makes integration and inference a non-trivial task. We developed a deep-learning-based framework, multi-omics variational autoencoders (MOVE), to integrate such data and applied it to a cohort of 789 people with newly diagnosed type 2 diabetes with deep multi-omics phenotyping from the DIRECT consortium. Using in silico perturbations, we identified drug–omics associations across the multi-modal datasets for the 20 most prevalent drugs given to people with type 2 diabetes with substantially higher sensitivity than univariate statistical tests. From these, we among others, identified novel associations between metformin and the gut microbiota as well as opposite molecular responses for the two statins, simvastatin and atorvastatin. We used the associations to quantify drug–drug similarities, assess the degree of polypharmacy and conclude that drug effects are distributed across the multi-omics modalities.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41587-022-01520-x

Cites

75 of 75 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Integration of multi-omics datasets with drug usage information has been used to identify drug-associated individual omics features, quantifying drug response effects.

    “The integration of multi-omics datasets with the drug usage information has been used to identify drug-associated individual omics features, quantifying the drug response effects [18].”
  • Froguel et al. introduced the MOVE framework for identifying associations between drug usage and multi-omics data features, helping characterize drug effects on type 2 diabetes.

    “Additionally, Froguel et al. introduced a multi-omics variational autoencoders (MOVE) framework for identifying the associations between drug usage and multi-omics data features, helping characterize the drug effects on type 2 diabetes [18].”
  • The MOVE framework utilized a perturbation-based approach to identify significant drug-related multimodal features in type 2 diabetes, providing a framework for interpreting biomedical multimodal datasets.

    “The MOVE framework utilized a perturbation-based approach to identify significant drug-related multimodal features in type 2 diabetes, providing a framework for interpreting biomedical multimodal datasets [18].”
  • The perturbation-based method has been effective in characterizing the most drug-responsive omics features.

    “Although the perturbation-based method has been effective in characterizing the most drug-responsive omics features [18], there is still a need for further research and discussions to improve cross-modal interpretation by refining model designs.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 76 references couldn’t be matched to a known paper.

Research works printed but not linked: 4

  1. [24]Mattei, P.-A. & Frellsen, J. MIWAE: deep generative modelling and imputation of incomplete data. In Proceedings of the 36th International Conference on Machine Learning 4413–4423 (PMLR, 2019).
  2. [31]Lopez, R., Boyeau, P., Yosef, N., Jordan, M. I. & Regier, J. Decision-making with auto-encoding variational Bayes. In Proceedings of the 34th International Conference on Neural Information Processing Systems 5081–5092 (Curran Associates Inc., 2020).
  3. [34]Lundberg, S. M. & Lee, S.-I. A unified approach to interpreting model predictions. in Advances in Neural Information Processing Systems 30 (eds Guyon, I. et al.) 4765–4774 (Curran Associates, 2017).
  4. [68]Maas, A. L., Hannun, A. Y. & Ng, A. Y. Rectifier nonlinearities improve neural network acoustic models. In Proc. 30th International Conference on Machine Learning (eds Dasgupta, S. & McAllester, D.) (JMLR, 2013).

Cited by

Sorted by citations

Authors
Allesøe, R. L., Lundgaard, A. T., Hernández Medina, R., Aguayo-Orozco, A., Johansen, J., Nissen, J. N., Brorsson, C., Mazzoni, G., Niu, L., Biel, J. H., Leal Rodríguez, C., Brasas, V., Webel, H., Benros, M. E., Pedersen, A. G., Chmura, P. J., Jacobsen, U. P., Mari, A., Koivula, R., Mahajan, A., Vinuela, A., Tajes, J. F., Sharma, S., Haid, M., Hong, M.-G., Musholt, P. B., De Masi, F., Vogt, J., Pedersen, H. K., Gudmundsdottir, V., Jones, A., Kennedy, G., Bell, J., Thomas, E. L., Frost, G., Thomsen, H., Hansen, E., Hansen, T. H., Vestergaard, H., Muilwijk, M., Blom, M. T., ‘t Hart, L. M., Pattou, F., Raverdy, V., Brage, S., Kokkola, T., Heggie, A., McEvoy, D., Mourby, M., Kaye, J., Hattersley, A., McDonald, T., Ridderstråle, M., Walker, M., Forgie, I., Giordano, G. N., Pavo, I., Ruetten, H., Pedersen, O., Hansen, T., Dermitzakis, E., Franks, P. W., Schwenk, J. M., Adamski, J., McCarthy, M. I., Pearson, E., Banasik, K., Rasmussen, S., Brunak, S., IMI DIRECT Consortium, Froguel, P., Thomas, C. E., Haussler, R., Beulens, J., Rutters, F., Nijpels, G., van Oort, S., Groeneveld, L., Elders, P., Giorgino, T., Rodriquez, M., Nice, R., Perry, M., Bianzano, S., Graefe-Mody, U., Hennige, A., Grempler, R., Baum, P., Stærfeldt, H.-H., Shah, N., Teare, H., Ehrhardt, B., Tillner, J., Dings, C., Lehr, T., Scherer, N., Sihinevich, I., Cabrelli, L., Loftus, H., Bizzotto, R., Tura, A., Dekkers, K., van Leeuwen, N., Groop, L., Slieker, R., Ramisch, A., Jennison, C., McVittie, I., Frau, F., Steckel-Hamann, B., Adragni, K., Thomas, M., Pasdar, N. A., Fitipaldi, H., Kurbasic, A., Mutie, P., Pomares-Millan, H., Bonnefond, A., Canouil, M., Caiazzo, R., Verkindt, H., Holl, R., Kuulasmaa, T., Deshmukh, H., Cederberg, H., Laakso, M., Vangipurapu, J., Dale, M., Thorand, B., Nicolay, C., Fritsche, A., Hill, A., Hudson, M., Thorne, C., Allin, K., Arumugam, M., Jonsson, A., Engelbrechtsen, L., Forman, A., Dutta, A., Sondertoft, N., Fan, Y., Gough, S., Robertson, N., McRobert, N., Wesolowska-Andersen, A., Brown, A., Davtian, D., Dawed, A., Donnelly, L., Palmer, C., White, M., Ferrer, J., Whitcher, B., Artati, A., Prehn, C., Adam, J., Grallert, H., Gupta, R., Sackett, P. W., Nilsson, B., Tsirigos, K., Eriksen, R., Jablonka, B., Uhlen, M., Gassenhuber, J., Baltauss, T., de Preville, N., Klintenberg, M., & Abdalla, M.
Affiliations
  • University of Copenhagen (DK)
  • Technical University of Denmark (DK)
  • Centre for Human Genetics (GB)
  • Helmholtz Munich (DE)
  • Science for Life Laboratory (SE)
  • Sanofi (Germany) (DE)
  • University of Exeter (GB)
  • University of Dundee (GB)
  • University of Westminster (GB)
  • Imperial College London (GB)
  • Herlev Hospital (DK)
  • Amsterdam Public Health (NL)
  • Inserm (FR)
  • University of Eastern Finland (FI)
  • Newcastle University (GB)
  • Royal Victoria Infirmary (GB)
  • University of Oxford (GB)
  • Lund University (SE)
  • Eli Lilly (United States) (US)
  • University of Geneva (CH)
  • Harvard University (US)
  • University of Ljubljana (SI)
  • Institut de Recherches Internationales Servier (France) (FR)
  • Royal Devon & Exeter NHS Foundation Trust (GB)
  • Boehringer Ingelheim (Germany) (DE)
  • University of Bath (GB)
  • Saarland University (DE)
  • Leiden University Medical Center (NL)
  • Universität Ulm (DE)
  • Eli Lilly (Germany) (DE)
  • University of Tübingen (DE)
  • Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas (ES)
Corresponding author
  • Rasmussen, Simon
  • Brunak, Søren
ORCID
Venue
Nature Biotechnology
Published
2023-01-02
Volume
41
Issue
3
Pages
399-408
ISSN
  • 0733-222X (ISSN-L)
  • 1087-0156
  • 1546-1696
OpenAlex
W4313455000
Cited by
111
References
76
Citations by year
2026: 25 · 2025: 35 · 2024: 34 · 2023: 17
FWCI
9.89
Type
journal article
Language
en
Open access
Locations
  • Nature Biotechnology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Discovery Research Portal (University of Dundee) (publishedVersion, cc-by)
  • Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion, other-oa)
  • Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by)
  • Repositori digital de la UPF (Universitat Pompeu Fabra) (acceptedVersion, cc-by)
  • WestminsterResearch (University of Westminster) (acceptedVersion, cc-by)
  • Pure Amsterdam UMC (submittedVersion, cc-by)
  • Technical University of Denmark, DTU Orbit (Technical University of Denmark, DTU) (submittedVersion, cc-by)
  • Leiden Repository (Leiden University) (submittedVersion, cc-by)
  • Apollo (University of Cambridge) (submittedVersion, cc-by)
  • CNR ExploRA (submittedVersion, cc-by)
  • Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
  • Data Archiving and Networked Services (DANS) (submittedVersion, cc-by)
  • HAL (submittedVersion)
  • LillOA (Université de Lille (University Of Lille)) (submittedVersion, cc-by)
  • Lund University Publications (Lund University) (submittedVersion)
  • mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
  • Apollo (cc-by)
  • Apollo
Funders
  • Novo Nordisk Fonden (NNF14CC0001, NNF17OC0027594)
  • Innovative Medicines Initiative (115317)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
  • Physical Sciences › Computer Science › Computational Theory and Mathematics › Computational Drug Discovery Methods
  • Physical Sciences › Computer Science › Artificial Intelligence › Machine Learning in Healthcare
Keywords
type 2 diabetes, multi-omics integration, variational autoencoder, metformin, gut microbiota, statins, simvastatin, atorvastatin, polypharmacy, drug-drug similarity
MeSH terms
Deep Learning, Algorithms, Diabetes Mellitus, Type 2, Humans

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review